Harwell, United Kingdom

Hayley Binch

This inventor holds 28 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 10 EPO patents, primarily in Protein Kinase Inhibitors. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2003-2014.

USPTO Granted Patents = 28 

% Patents Active = 28.6


 

Average Co-Inventor Count = 7.8

ph-index = 19

Forward Citations = 1,163(Granted Patents)


Location History:

  • Encinitas, GB (2010)
  • San Diego, CA (US) (2009 - 2012)
  • Harwell, GB (2003 - 2014)

Company Filing History:


Years Active: 2003-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Protein Kinases
CGRP Antagonists
Aminopyrimidines
Pyrrolopyrazines
Benzimidazoles
Triazole Compounds
Azaindoles
Caspase Inhibitors
Indazole Compounds
Fused Pyrimidyl Pyrazoles
Pyrazole Compounds
Diaminotriazoles
28 patents (USPTO):Explore Patents

Title: The Innovative Journey of Hayley Binch

Introduction: Hayley Binch, a pioneering inventor based in Harwell, GB, has been making significant contributions to the world of technology and innovation.

Latest Patents: Hayley Binch's latest patents focus on sustainable energy solutions, with a series of inventions aimed at revolutionizing the renewable energy sector.

Career Highlights: With a background in engineering and a passion for environmental sustainability, Hayley Binch has led groundbreaking projects that have garnered international recognition. Her innovative approach to problem-solving has led to the development of cutting-edge technologies.

Collaborations: Throughout her career, Hayley Binch has collaborated with leading research institutions and universities to further her inventions. Her partnerships with top experts in the field have resulted in the successful implementation of her ideas.

Conclusion: Hayley Binch's dedication to innovation and her commitment to creating a more sustainable future make her a standout figure in the world of inventors. Her work continues to inspire and shape the landscape of technological advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…